A new clinical trial, co-led by endocrinologist and diabetes expert John Buse, MD, PhD, and interventional cardiologist Matthew Cavender, MD, MPH, at the UNC School of Medicine has shown that the oral form of semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes and atherosclerotic cardiovascular disease, and/or chronic kidney disease
Ridlon and Gaskins, 2024), this section will focus exclusively on relevant research that has been conducted in fish
2 GLP-1RAs as Favorable Factors for Myelin Formation and Maintenance 2.1 ALS Models There is increasing evidence that impaired GLP-1 signaling is associated with the progression of ALS ( 2.2 Wolfram Syndrome Model Wolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder characterized by childhood-onset diabetes mellitus and various neurological manifestations, including progressive optic nerve atrophy, sensorineural hearing loss and cognitive impairment ( 2.3 Nerve Injury Models 2.4 Diabetic Neuropathy Models There is enough evidence that the main pathology of diabetic neuropathy is axonal degeneration, which precedes demyelination observed in patients with the disease at advanced stages ( 2.5 NeuronSchwann Cell Co-Culture Models Co-culture systems of neurons and Schwann cells have enabled us to generate myelin structures nearly equivalent to those in living bodies, thereby being recognized as useful tools to investigate neuron-Schwann cell interactions (Figure 1A)
After the results are submitted to the agency, the FDA would review the results, as well as the drugs positive and negative effects, the treatments currently available for the proposed use, and more
